Ian Stewart

Ian Stewart is a results-oriented business professional with more than two decades of experience in managing the identification, evaluation, development, and commercialization of scientific research opportunities across various sectors. He has a successful track record in team building and execution, with a collaborative and consultative approach to developing and negotiating partnership agreements. Ian has excelled in developing opportunities within the early-stage life sciences sector, particularly in areas like therapeutics, diagnostics, and medical devices. His expertise includes deal flow in biologics, genomic screening technologies, small molecule development programs, and the commercialization of ICT and physical sciences technologies. Ian's skillset encompasses business development, transaction development, licensing negotiation and execution, private investment attraction, public funding attraction for technology development and commercialization, as well as pre-clinical drug development.

Ian Stewart holds a Master of Business Administration in Finance from the University of Toronto's Rotman School of Management. He pursued Chemistry studies at The Ohio State University, completed a Doctor of Philosophy in Chemistry at the University of Alberta, and obtained a Bachelor of Science in Chemistry from the University of Manitoba. Ian’s professional background includes roles such as Senior Manager of Commercialization and Business Development at the University of Toronto, CEO and President at The Centre for the Commercialization of Antibodies and Biologics, Vice President of Business Development at the same center, Partner at Infochromics, Director of Analytical Sciences at Protan As, Associate Director at MDS Proteomics, and Research Associate and Officer at the National Research Council Canada / Conseil National de Recherches Canada.